Prevention over screening for ovarian cancer in patients with high-risk germline mutations: Misinterpreting the findings of ALDO

In November 2022, the findings of the Avoiding Late Diagnosis of Ovarian cancer (ALDO) study were published. Subsequent media coverage suggested that investigators had found a safe alternative to risk-reducing bilateral salpingoophorectomy (rrBSO) in patients with pathogenic BRCA1 and BRCA2 germline...

Descripción completa

Detalles Bibliográficos
Autores principales: Manning-Geist, Beryl L., Flint, Matthew, Roche, Kara Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020112/
https://www.ncbi.nlm.nih.gov/pubmed/36938343
http://dx.doi.org/10.1016/j.gore.2023.101157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020112/
https://www.ncbi.nlm.nih.gov/pubmed/36938343
http://dx.doi.org/10.1016/j.gore.2023.101157

Ejemplares similares